Search Results

Filter
  • 1-10 of  93,434 results for ""Factor Xa""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Detection of factor Xa activity using giant magnetoresistive biosensors.

  • Authors : Lee Y; Department of Mechanical and Biomedical Engineering, Ewha Womans University, Seoul, 03760, Republic of Korea; Graduate Program in Smart Factory, Ewha Womans University, Seoul, 03760, Republic of Korea.

Subjects: Biosensing Techniques*/Biosensing Techniques*/Biosensing Techniques*/methods ; Factor Xa*/Factor Xa*/Factor Xa*/metabolism ; Factor Xa*/Factor Xa*/Factor Xa*/chemistry

  • Source: Analytica chimica acta [Anal Chim Acta] 2024 Dec 01; Vol. 1331, pp. 343347. Date of Electronic Publication: 2024 Oct 16.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370534 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors.

  • Authors : Fera T; Project Consultant, Greater Pittsburgh Area, PA, USA.; Burnett A

Subjects: Factor Xa Inhibitors* ; Recombinant Proteins*/Recombinant Proteins*/Recombinant Proteins*/administration & dosage ; Factor Xa*/Factor Xa*/Factor Xa*/therapeutic use

  • Source: Journal of pharmacy practice [J Pharm Pract] 2025 Feb; Vol. 38 (1), pp. 7-12. Date of Electronic Publication: 2024 Jul 20.Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Conformation of factor Xa in solution revealed by single-molecule spectroscopy.

  • Authors : Stojanovski BM; Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri, USA.; Di Cera E

Subjects: Factor Xa*/Factor Xa*/Factor Xa*/metabolism ; Factor Xa*/Factor Xa*/Factor Xa*/chemistry ; Protein Conformation*

  • Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Oct; Vol. 22 (10), pp. 2767-2772. Date of Electronic Publication: 2024 Jul 11.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836

Record details

×
Editorial & Opinion

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.

  • Authors : Yates SG; University of Texas Southwestern Medical Center, Dallas, TX .; Sarode R

Subjects: Cerebral Hemorrhage*/Cerebral Hemorrhage*/Cerebral Hemorrhage*/chemically induced ; Cerebral Hemorrhage*/Cerebral Hemorrhage*/Cerebral Hemorrhage*/drug therapy ; Factor Xa*/Factor Xa*/Factor Xa*/administration & dosage

  • Source: The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 773-774.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis.

  • Authors : White CM; University of Connecticut School of Pharmacy, Storrs, Connecticut, USA.; Hartford Hospital Health Outcomes, Policy and Evidence Synthesis Group, Hartford, Connecticut, USA.

Subjects: Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/adverse effects ; Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/therapeutic use ; Hemorrhage*/Hemorrhage*/Hemorrhage*/chemically induced

  • Source: Pharmacotherapy [Pharmacotherapy] 2024 May; Vol. 44 (5), pp. 394-408. Date of Electronic Publication: 2024 May 09.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in vitro.

  • Authors : Mishima Y; Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Butt AL

Subjects: Antithrombins*/Antithrombins*/Antithrombins*/pharmacology ; Drug Resistance*/Drug Resistance*/Drug Resistance*/drug effects ; Factor Xa*/Factor Xa*/Factor Xa*/metabolism

  • Source: British journal of anaesthesia [Br J Anaesth] 2024 Jun; Vol. 132 (6), pp. 1204-1210. Date of Electronic Publication: 2024 Apr 08.Publisher: Elsevier Country of Publication: England NLM ID: 0372541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-6771

Record details

×
Academic Journal

Real-World Reversal of Factor Xa Inhibition in the Setting of Major Life-Threatening Bleeding or Urgent Surgery.

  • Authors : Schmidt LE; Department of Pharmacy, Penn Presbyterian Medical Center, Philadelphia, PA, USA.; Hinton MS

Subjects: Factor Xa*/Factor Xa*/Factor Xa*/therapeutic use ; Hemostatics*/Hemostatics*/Hemostatics*/adverse effects; Humans

  • Source: Journal of pharmacy practice [J Pharm Pract] 2024 Feb; Vol. 37 (1), pp. 74-79. Date of Electronic Publication: 2022 Sep 09.Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Emicizumab promotes factor Xa generation on endothelial cells.

  • Authors : Fager AM; Hematology/Oncology Service, Department of Veterans Affairs Medical Center, Durham, North Carolina, USA; Division of Hematology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: .

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/pharmacology ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/pharmacology ; Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/metabolism

  • Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Jun; Vol. 22 (6), pp. 1605-1615. Date of Electronic Publication: 2024 Mar 08.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836

Record details

×
Academic Journal

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.

Subjects: Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/adverse effects ; Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/therapeutic use ; Cerebral Hemorrhage*/Cerebral Hemorrhage*/Cerebral Hemorrhage*/drug therapy

  • Source: The New England journal of medicine [N Engl J Med] 2024 May 16; Vol. 390 (19), pp. 1745-1755.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Andexanet alfa or prothrombin complex concentrate for acute reversal of oral factor Xa inhibitors: monitoring of antidote effects.

  • Authors : Tanaka KA; Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: .; Levy JH

Subjects: Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/pharmacology ; Antidotes*/Antidotes*/Antidotes*/pharmacology ; Antidotes*/Antidotes*/Antidotes*/therapeutic use

  • Source: British journal of anaesthesia [Br J Anaesth] 2024 Feb; Vol. 132 (2), pp. 215-217. Date of Electronic Publication: 2023 Dec 08.Publisher: Elsevier Country of Publication: England NLM ID: 0372541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-6771

Record details

×
  • 1-10 of  93,434 results for ""Factor Xa""